# Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

> **NCT02680717** · PHASE1 · WITHDRAWN · sponsor: **Medical College of Wisconsin**

## Conditions studied

- Scleroderma

## Interventions

- **DRUG:** Clobetasol
- **DRUG:** Calcipotriene
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT02680717
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to obtain IRB approval at all sites
- **Last updated:** 2018-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680717, "Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02680717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*